CRISPR Therapeutics to Present at the 42nd Annual Deutsche Bank Health Care Conference – GlobeNewswire (press release)
The Cerbat Gem |
CRISPR Therapeutics to Present at the 42nd Annual Deutsche Bank Health Care Conference
GlobeNewswire (press release) BASEL, Switzerland and CAMBRIDGE, Mass., April 27, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today … Intellia (NTLA), CRISPR Therapeutics (CRSP) Receive U.S. Patent for CRISPR/Cas9 Ribonucleoprotein Complexes Variation on CRISPR technology advances potential cures | The … Crispr Therapeutics AG (CRSP) Coverage Initiated at Chardan Capital |
